2025 annual financial data
Corvus Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was 75.47%.
Operating income was -42,971,000 USD and net income was -15,283,000 USD.
Operating cash flow was -32,797,000 USD.
Get free Corvus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -42,971,000 USD
- Net income
- -15,283,000 USD
- Operating cash flow
- -32,797,000 USD